Cantor Fitzgerald Reiterates Exagen (XGN) Overweight Recommendation
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
Fintel reports that on August 22, 2023, Cantor Fitzgerald reiterated coverage of Exagen (NASDAQ:XGN) with a Overweight recommendation.
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-2007594509-ba97533a0736449eb4661aa3324f7d5b.jpg "Why Should I Pay Myself First?")